|
|
Volumn 148, Issue 3, 2008, Pages 243-
|
|
Ampicillin plus ceftriaxone for high-level aminoglycoside-resistant Enterococcus faecalis endocarditis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPICILLIN;
BETA LACTAM ANTIBIOTIC;
CEFTRIAXONE;
CEPHALOSPORIN;
PEPTIDOGLYCAN;
STREPTOMYCIN;
AMINOGLYCOSIDE;
ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL ENDOCARDITIS;
BACTERICIDAL ACTIVITY;
DRUG MECHANISM;
DRUG MONITORING;
DRUG POTENTIATION;
ENTEROCOCCUS FAECALIS;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
PRIORITY JOURNAL;
DRUG COMBINATION;
DRUG EFFECT;
HUMAN;
NOTE;
AMINOGLYCOSIDES;
AMPICILLIN;
ANTI-BACTERIAL AGENTS;
CEFTRIAXONE;
DRUG RESISTANCE, BACTERIAL;
DRUG THERAPY, COMBINATION;
ENDOCARDITIS, BACTERIAL;
ENTEROCOCCUS FAECALIS;
HUMANS;
|
|
EID: 39349105626
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-3-200802050-00012 Document Type: Letter |
|
Times cited : (2)
|
|
References (4)
|
